Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$992,037
+$6,036 QoQ
Shares Held
6,330
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#621
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEANS INVESTMENT CO., INC. holds $25,645,348 across 8 Drug Manufacturers - General names. NVS ranks #5 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,110 | $7,139,096 | |
| 2 | ABBV |
AbbVie Inc.
|
22,908 | $5,764,569 | |
| 3 | LLY |
ELI LILLY & Co
|
4,726 | $5,668,506 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,981 | $3,595,558 | |
| 5 | NVS |
Novartis AG
This page
|
6,330 | $992,037 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,080 | $984,149 | |
| 7 | AMGN |
Amgen Inc
|
2,444 | $885,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,879 | $616,412 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $992,037 | 6,330 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $986,001 | 6,455 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $908,149 | 6,587 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $844,716 | 6,587 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $860,623 | 7,112 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $787,717 | 7,066 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $710,946 | 7,306 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $863,340 | 7,506 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $799,088 | 7,506 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $743,273 | 7,684 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $815,231 | 8,074 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $811,926 | 7,971 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $815,655 | 8,083 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $741,520 | 8,060 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $743,813 | 8,199 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $625,486 | 8,229 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $695,597 | 8,229 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $730,869 | 8,329 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $722,764 | 8,263 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $676,893 | 8,277 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $704,737 | 7,724 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $660,247 | 7,724 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $775,742 | 8,215 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $711,767 | 8,185 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $714,877 | 8,185 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $674,853 | 8,185 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||